Content reviewed · Sources & review policy
Answer first: Keep Palmitoyl Tetrapeptide-7 separate from Palmitoyl Tripeptide-1 in the ingredient register.
What exactly is this Palmitoyl Tetrapeptide-7 enquiry for?
Keep Palmitoyl Tetrapeptide-7 separate from Palmitoyl Tripeptide-1 in the ingredient register. They may be discussed together in a blend project, but one does not stand in for the other. A two-component brief needs a declared ratio basis and carrier composition.
This page defines an enquiry target, not a released batch specification. Request the current material document before assigning a CAS reference, purity, content or expiry value to the purchase. Keep the confirmed fields separate from open technical questions so your sample request and quotation refer to the same item. If a proposed material differs from the requested identity or form, ask for that difference to be stated clearly before comparison.
The initial review should identify the product code, exact composition and document revision, with a named owner for any unresolved identity question.
- Enquiry identity: Palmitoyl Tetrapeptide-7
- Use: cosmetic formulation only
- Status: batch results, MOQ and lead time require confirmation
What should I evaluate in the cosmetic formulation?
For a combined palmitoyl-peptide concept, compare each component and then evaluate the proposed mixture in the intended base. The total blend percentage cannot describe each peptide amount unless the component concentrations and calculation basis are known. Preserve those details when moving from a sample to a bulk quotation.
Use a documented screening plan for the actual cosmetic base and presentation. Record the sample lot, supplied form, proposed addition basis, processing conditions and observations. Define the criteria for proceeding before the sample is evaluated. A successful compatibility check is not automatically a finished-product stability result or evidence for a marketing claim; those decisions need their own supporting review.
Keep the material and formulation versions together in the trial record so a later change in carrier, ingredient or packaging can be assessed against the original sample.
- Sample record: lot, composition, base and processing conditions
- Observations: appearance, compatibility and agreed technical criteria
- Boundary: no injection, therapeutic or universal performance claim
What should I request before ordering?
A useful quotation for Palmitoyl Tetrapeptide-7 needs the intended cosmetic application, exact material identity, target quantity and required delivery format. Ask for separate material, filling, packaging and analytical scope where relevant. A discussion of sample quantities or vial sizes is a feasibility request, not a confirmed minimum or stock statement.
Before ordering, match the quotation to the available specification, batch COA, technical data sheet and safety data sheet. Record which requested documents are available and which still need confirmation. Agree the sample acceptance criteria, commercial approval steps and supported shipping conditions in writing. Keep total powder fill distinct from a measured or specified target-peptide amount, especially when a carrier-containing preparation or custom blend is proposed.
Specify the quotation currency, validity and any excluded work so repeat orders can be compared on the same basis.
Specification fields
- Ingredient identity: Palmitoyl Tetrapeptide-7
- CAS / identity reference: Confirmed on the exact ingredient specification; salt and sequence may affect identification.
- Grade / use: For cosmetic formulation only
- Purity / assay: Project-specific acceptance criteria; request current analytical method and batch COA.
- Appearance: Powder or lyophilized cake; appearance confirmed with specification
- Solubility: Ingredient- and carrier-dependent; request TDS and evaluate a small sample.
- Storage / shelf life: Follow batch label and TDS; keep sealed and protect from moisture and light.
- Pack options: Bulk packs; custom vial fill targets such as 5, 10, 20, 50 or 100 mg, subject to technical review.
- MOQ / price / lead time: Quoted after identity, quantity, format and documentation review.
Frequently asked questions
Is Palmitoyl Tetrapeptide-7 alone Matrixyl 3000?
No. A branded multi-component preparation is not the same purchasing item as an individual peptide.
What is confirmed about MOQ and delivery for Palmitoyl Tetrapeptide-7?
No fixed MOQ, stock status or lead time is verified on this page. Submit the material, quantity and format for a written quotation.
